New Analysis of UK Study Shows Rifaximin-α Significantly Reduces Number of Emergency Department Attendances for Patients With Hepa
– Norgine B.V. today presented a new analysis from the UK real world study IMPRESS, that shows treatment with rifaximin-α for hepatic encephalopathy could significantly…